Skip to main content
Clinical Trials/NCT06755047
NCT06755047
Recruiting
Not Applicable

3D Ultrasound Placental Volume and Vascular Indices Versus 2D Parameters for Diagnosis of Placenta Accreta Spectrum

Assiut University1 site in 1 country38 target enrollmentDecember 31, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Placenta Accreta
Sponsor
Assiut University
Enrollment
38
Locations
1
Primary Endpoint
Vascular index
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Placenta Accreta spectrum is a major obstetric disease nowadays. Different methods are used for antenatal diagnosis. In our study, investigators are aiming to compare 2 common ways for diagnosis, i.e; 3D Ultrasound and 2D with color Doppler.

Detailed Description

The word placenta accreta spectrum disorders (PASD) implies an atypical implantation of the placenta into the uterine wall and has been used to express placenta accreta, increta and percreta. Placenta accreta is a placenta where the placental villi sick on directly to the myometrium. Placenta increta is a placenta where the placental villi attack into the myometrium and placenta percreta is a placenta where the villi invade through the myometrium and into serosa. No antenatal diagnostic method gives the clinician 100% assurance of either ruling in or ruling out the existence of placenta accreta. The definitive diagnosis of placental accreta spectrum is frequently ended postpartum on hysterectomy specimens when an area of accretion shows chorionic villi which make direct contact with the myometrium and absence of deciduae. Antenatal ultrasound is the method of choice used to establish the diagnosis and direct clinical management.The combined use of power Doppler with three dimensional (3D) ultrasound provides the possibility of quantifying moving blood within a volume of interest. Three indices are calculated, namely vascularization index (VI), flow index and vascularization flow index

Registry
clinicaltrials.gov
Start Date
December 31, 2024
End Date
May 2025
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mohamed Gamal M.fekry

Lecturer obstetric and gynecology, Specialist Urogynecology

Assiut University

Eligibility Criteria

Inclusion Criteria

  • pregnant women with placenta previa

Exclusion Criteria

  • congenital anomalies of placenta Placental separation Uterine anomalies

Outcomes

Primary Outcomes

Vascular index

Time Frame: 1 months

3D Vascularization index

Secondary Outcomes

  • 2D ultrasound(1 months)

Study Sites (1)

Loading locations...

Similar Trials